Karos Oral Spray 0.3% IBSA 20ml

Karos Oral Spray 0.3% IBSA - Medical Device

Karos Oral Spray is a solution based on hyaluronic acid to nabulize in the throat in case of oropharyngeal mucosal inflammation (inflammation of the oryl and pharyngeal mucosa).

Hyaluronic acid, thanks to its viscoelastic and physical properties, forms a protective barrier on the inflamed oropharyngeal mucosa ; in fact, being a hydrophilic molecule, it is able to absorb water up to 1000 times its volume, forming almost a gel.
For this reason, the nebulization of Karos oral spray based on hyaluronic acid, directly in the aqueous environment of the oropharyngeal area, allows the formation of a thin film. This film acts as a protective barrier for the pharyngolaryngeal mucosa in case of mucosal inflammation caused by non-erosive gastroesophageal reflux disease (NERD) or by diseases of the upper respiratory tract , such as pharyngitis and laryngitis, both in the acute and chronic phase. Reflux disease is a remarkably widespread disease, especially in the Western world and is closely linked to lifestyle and eating habits.

Reflux in the oral cavity and precisely in the pharynx and larynx of the gastric juices contained in the stomach is recognized within the category of non-erosive gastroesophageal reflux disease (NERD) and is defined as pharyngolaryngeal reflux disease, often abbreviated as RFL (in English LPR, Laryngo-Pnaryngeal Reflux).
In this disease the gastroduodenal contents refluxed from the stomach exceeds the antireflux barrier of the upper esophageal sphincter and spreads into the aqueous environment typical of the oropharyngeal area, irritating and inflaming the mucosa of the pharyngolaryngeal region and causing various symptoms, such as: dysphonia , need to clear throat, need to scrape throat, excess mucus in throat, feelings of post-nasal discharge, chronic cough, pharyngeal globe with foreign body sensation.
The same sontomas can be associated with mucosal inflammation due to affections of the upper respiratory tract; also in this case the protective barrier created by the hyaluronic acid present in Karos oral spray relieves the painful symptoms of pharyngitis and laryngitis, acute or chronic, and moreover, thanks to the ability of hyaluronic acid to recall and retain water, it also allows a fluidifying action of the mucus.

Indications

Karos oral spray is indicated in the treatment of symptoms related to oropharyngeal mucosal inflammation (inflammation of the mucous membrane of the mouth up to the pharynx) such as: inflammation of the vocal cords with and without dysphonia (voice disorders), hoarseness, need to clear the throat, need for scratching of the throat, excess mucus in the throat, sensation of post-nasal discharge, chronic cough, pharyngeal globe with foreign body sensation (sensation of constriction or foreign body in the throat), when these disorders are related to pharyngolangeal reflux disease ( RFL) or affections of the upper respiratory tract such as pharyngitis and laryngitis, both in the acute and chronic phase.
Karos oral spray is added to and does not replace other therapeutic treatments that may be prescribed to patients.

Composition

Each 20 ml multidose bottle contains: sodium hyaluronate 0.3% hyaluronic acid, sodium salt), sodium doride, potassium sorbate, sodium benzoate, citric acid, purified water.

Frequency of use

We recommend 2 puffs in the mouth 3 times a day, 1 hour after meals.
Continue the treatment for a period of 2 weeks, unless otherwise indicated by the doctor.
140 microliters of solution are dispensed with each spray.

How to use

Press on the dispenser, directing the jet towards the back of the oral cavity.
Keep the bottle upright. Shake before using.
Do not use any food or drink for about 1 hour after the treatment.

Warnings

Do not use Karso oral spray after the expiry date stated on the package.
Do not use Karso oral spray if the packaging is open or damaged.
Do not take any food or drink for approximately 1 hour after treatment with KAaros oral spray.
Store between 0 ° C and 25 ° C. Do not freeze.
Once used, dispose of the bottle following the normal rules for separate disposal of municipal waste.
It is advisable to consult your doctor before using Karos oral spray.
Keep out of the reach and sight of children.

Interactions

At the moment, there are no known interactions between Karos oral spray and any concomitant therapies.
However, since Karos oral spray consists of physiological solution and hyaluronic acid, a natural constituent of human tissues, these interactions are, in principle, to be excluded.

Contraindications and side effects

There are currently no contraindications to the use of Karos oral spray, nor side effects have been reported, however the product should not be used in case of known hypersensitivity to sodium hyaluronate or to the other components.
If unwanted effects occur, it is advisable to stop the treatment and consult your doctor.

Format

Karos oral spray is a solution for oral administration.

The package contains 1 multidose bottle of 20 ml.